Fortrea Holdings (FTRE)

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

的Fortrea Holdings Inc. Common Stock（FTRE）股票的价格今天是$10.39，自市场开启。该公司市值为$9.60亿，日交易量为股。前一交易日收盘价为 $10.49。

您准备好开始了吗？按照以下步骤操作，或阅读我们关于在Kraken上从10美元起购买Fortrea Holdings股票的指南。